Jose Luis Vazquez Martinez

Source: Popova, S., Lange, S., Shield, K., Burd, L., and Rehm, J. ( 2019) Prevalence of fetal alcohol spectrum disorder among special subpopulations: a systematic review and meta‐analysis. Addiction

Jose Luis Vazquez Martinez

This webinar, sponsored by the Northwest ATTC and the Western States Node of the NIDA Clinical Trials Network, summarized what makes women's treatment for substance use disorder (SUD) unique from men's treatment and highlighted key issues when providing treatment to pregnant and parenting women w

Use of Electronic Vapor Products Before, During, and After Pregnancy Among Women with a Recent Live Birth — Oklahoma and Texas, 2015


What is already known about this topic?

Most electronic vapor products (EVPs) contain nicotine, a developmental toxicant, and other harmful additives.

What is added by this report?

In 2015, 7.0% of women with a recent live birth in Oklahoma and Texas reported using EVPs shortly before, during, or after pregnancy, with 1.4% reporting use during pregnancy. Among prenatal EVP users, 38.4% reported using EVPs containing nicotine, and 26.4% did not know if the EVPs they used contained nicotine.

What are the implications for public health practice?

Messages that EVPs are not safe to use during pregnancy need to be clearly communicated. Education, counseling, and evidence-based cessation treatment could assist reproductive-aged women in preventing or reducing the use of all tobacco products, including EVPs.

Jose Luis Vazquez Martinez

Most electronic vapor products (EVPs) contain nicotine, a developmental toxicant, and other harmful additives.

Jose Luis Vazquez Martinez

Source: Nafeesa N Dhalwani, Lisa Szatkowski, Tim Coleman, Linda Fiaschi, Laila J Tata, Stillbirth Among Women Prescribed Nicotine Replacement Therapy in Pregnancy: Analysis of a Large UK Pregnancy Cohort, Nicotine & Tobacco Research, Volume 21, Issue 4, April 2019, Pages 409–415, 

Assessing Prenatal Alcohol Exposure in a Study of Foetal Alcohol Spectrum Disorder

Foetal Alcohol Spectrum Disorder (FASD) is a diagnostic term used to describe physical, neurodevelopmental, and cognitive impairments that have occurred following exposure to alcohol during pregnancyThe diagnosis of FASD requires a complex assessment and confirmation of maternal alcohol consumption during pregnancy. Obtaining accurate and reliable assessment results can be difficult.

Researchers from the University of Western Australia have conducted a study to assess the challenges practitioners face when trying to gain information about prenatal alcohol exposure as part of a broader FASD assessment.

Interviews were carried out with the birth mother or responsible adult for 88 young people sentenced to detention in Western Australia.

Results found that:

  • The birth mother provided information on prenatal alcohol exposure for 55 (63%) of the 88 young people. The other remaining accounts of prenatal alcohol exposure were mostly from relatives.
  • Of the 88 young people with information on prenatal alcohol exposure, 41 (47%) had no reported prenatal alcohol exposure, 19 (22%) had either unknown or moderatequantity prenatal alcohol exposure, and 28 (32%) reported prenatal alcohol exposure at highrisk levels
  • 54% consumed a drink containing alcohol during pregnancy.
  • The most common reported number of standard drinks containing alcohol consumed on a typical day during pregnancy was 7 to 9 drinks (26%)
  • Only 29 of the 47 sources that confirmed prenatal alcohol exposure provided enough information to complete the questionnaire.

Obtaining a reliable measure of prenatal alcohol exposure using maternal recall and selfreport is likely to be limited due to suspected underreporting and lack of clarity as to what constitutes a standard drink. It is likely this is influenced by social stigma and recall bias. The authors suggest standardized recording on all antenatal birth records would aid later assessment for FASD and provide opportunities for advice and support for women who continue to drink.

Jose Luis Vazquez Martinez

This webinar, "Research and Evaluation of Treatment and Treatment Systems for Pregnant/Parenting Women with Opioid Use Disorder," is the third of a series of discussions pertaining to CTN collaborations with CSAT.